✦ LIBER ✦

ChemInform Abstract: The Discovery of Rofecoxib, [MK 966, Vioxx®, 4-(4′-Methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an Orally Active Cyclooxygenase-2 Inhibitor.

✍ Scribed by P. Prasit; Z. Wang; et al. et al.

Publisher: John Wiley and Sons
Year: 2010
Weight: 32 KB
Volume: 30
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199943277

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Synthesis of Rofeco

ChemInform Abstract: Synthesis of Rofecoxib, (MK 0966, Vioxx® 4-(4′-Methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a Selective and Orally Active Inhibitor of Cyclooxygenase-2.

✍ Michel Therien; Jacques Yves Gauthier; Yves Leblanc; Serge Leger; Helene Perrier 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

ChemInform Abstract: Discovery of 4-Amin

ChemInform Abstract: Discovery of 4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido [2,3-d]pyrimidine (VI), an Orally Active, Non-Nucleoside Adenosine Kinase Inhibitor.

✍ Chih-Hung Lee; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

ChemInform Abstract: Discovery of N-[2-[

ChemInform Abstract: Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6- [3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl] -N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa.

✍ M. M. MORRISSEY; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

ChemInform Abstract: Discovery and Precl

ChemInform Abstract: Discovery and Preclinical Studies of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo [2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo Active Potent VEGFR-2 Inhibitor.

✍ Rejean Ruel; et al. et al. 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 20 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v